Cite
HARVARD Citation
Schuessler‐Lenz, M. et al. (2020). Regulators' Advice Can Make a Difference: European Medicines Agency Approval of Zynteglo for Beta Thalassemia. Clinical pharmacology & therapeutics. 107 (3), pp. 492-494. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Schuessler‐Lenz, M. et al. (2020). Regulators' Advice Can Make a Difference: European Medicines Agency Approval of Zynteglo for Beta Thalassemia. Clinical pharmacology & therapeutics. 107 (3), pp. 492-494. [Online].